PATENT CLAIM ANALYSIS

Application Number: 16090072
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["544", "238000"]

Abstract:
The present invention relates to a novel pyrimidine-4-carboxylic acid derivative having an anticancer activity, and the compound of the present invention is useful as a drug for treating and preventing tumor diseases.

Claim (Index 3):
The compound according to  claim 1 , wherein Q is a phenyl group, a biphenyl group, a naphthalenyl group, a furanyl group, a thiophenyl group, a pyrazolyl group, a pyridazinyl group or an indazolyl group;\n R is chlorine, fluorine, a trifluoromethyl group, a methoxy group, a 4-ethylpiperazin-1-yl group, a methyl group, an ethyl group, a propyl group, a 2-(dimethylamino)ethyl group, a 3-(dimethylamino)propyl group or a 3-(benzamido)propyl group; n is 0 or 1; and m is 0, 1 or 2, wherein a compound, wherein Q is a phenyl group, a biphenyl group or a naphthalenyl group, R is chlorine or fluorine, n is 0, and m is 1 or 2, is excluded.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.17241
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15689115', '14475762', '14923525', '14775405', '14994824']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7547744114739616
- 35 USC 102 Novelty (BERT): 0.5006780738206404
- Combined Prediction Score: 0.7293647777086295
- Mean Citation Score: 255.124242
- Max Citation Score: 261.55322
- Similarity Product: 211.8083618140149

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test